Phyto Chem (India) Limited (BOM:524808)
India · Delayed Price · Currency is INR 22.78
-0.87 (-3.68%)
At close: Jun 15, 2026
Phyto Chem (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 90.71 | 140.78 | 148.11 | 267.6 | 231.19 |
Other Revenue | 18.32 | 15 | 20 | - | - |
| 109.03 | 155.78 | 168.11 | 267.6 | 231.19 | |
Revenue Growth (YoY) | -30.01% | -7.33% | -37.18% | 15.75% | -48.03% |
Cost of Revenue | 85.84 | 116.49 | 130.85 | 180.27 | 153.08 |
Gross Profit | 23.19 | 39.3 | 37.26 | 87.34 | 78.12 |
Selling, General & Admin | 13.72 | 22.47 | 29.63 | 34.27 | 33.57 |
Other Operating Expenses | 9.77 | 13.74 | 19.07 | 25.28 | 25.4 |
Operating Expenses | 26.9 | 40.87 | 52.72 | 63.5 | 63.06 |
Operating Income | -3.71 | -1.57 | -15.46 | 23.84 | 15.05 |
Interest Expense | -15.02 | -17.94 | -19.77 | -20.91 | -20.85 |
Interest & Investment Income | - | 9.43 | 1.61 | 0.01 | 0.22 |
Currency Exchange Gain (Loss) | - | - | 0.03 | -0.53 | 7.66 |
Other Non Operating Income (Expenses) | - | -0.46 | -0.63 | -0.1 | -0.1 |
EBT Excluding Unusual Items | -18.73 | -10.54 | -34.22 | 2.31 | 1.97 |
Gain (Loss) on Sale of Assets | - | 0.06 | 0.83 | 0.33 | - |
Pretax Income | -18.73 | -10.48 | -33.39 | 2.64 | 1.97 |
Income Tax Expense | -0.7 | -0.57 | -0.09 | 0.42 | -0.33 |
Earnings From Continuing Operations | -18.03 | -9.92 | -33.31 | 2.22 | 2.3 |
Net Income | -18.03 | -9.92 | -33.31 | 2.22 | 2.3 |
Net Income to Common | -18.03 | -9.92 | -33.31 | 2.22 | 2.3 |
Net Income Growth | - | - | - | -3.26% | -53.38% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 |
Shares Change (YoY) | 0.06% | - | - | - | - |
EPS (Basic) | -4.19 | -2.31 | -7.75 | 0.52 | 0.53 |
EPS (Diluted) | -4.19 | -2.31 | -7.75 | 0.52 | 0.53 |
EPS Growth | - | - | - | -2.42% | -53.78% |
Free Cash Flow | 8.94 | 17.68 | 30.74 | 14.16 | 33 |
Free Cash Flow Per Share | 2.08 | 4.11 | 7.15 | 3.29 | 7.67 |
Gross Margin | 21.27% | 25.23% | 22.16% | 32.64% | 33.79% |
Operating Margin | -3.40% | -1.01% | -9.20% | 8.91% | 6.51% |
Profit Margin | -16.54% | -6.37% | -19.81% | 0.83% | 0.99% |
Free Cash Flow Margin | 8.20% | 11.35% | 18.29% | 5.29% | 14.27% |
EBITDA | -0.3 | 1.8 | -12.04 | 27.79 | 19.14 |
EBITDA Margin | -0.27% | 1.16% | -7.16% | 10.38% | 8.28% |
D&A For EBITDA | 3.41 | 3.37 | 3.42 | 3.95 | 4.09 |
EBIT | -3.71 | -1.57 | -15.46 | 23.84 | 15.05 |
EBIT Margin | -3.40% | -1.01% | -9.20% | 8.91% | 6.51% |
Effective Tax Rate | - | - | - | 15.85% | - |
Revenue as Reported | 109.03 | 165.51 | 171.3 | 269.19 | 244.12 |
Advertising Expenses | - | 0.12 | 0.15 | 0.12 | 0.18 |